After a bumpy ride in 2015, what trends can beneficial owners expect to see in the securities lending markets over the next 12 months?
After a bumpy ride in 2015, what trends can beneficial owners expect to see in the securities lending markets over the next 12 months? At BNY Mellon, we believe familiar regulatory and macro-economic developments will continue to influence the market, with three key themes playing a particularly significant role in the decision-making process for securities lending clients. Two of these themes – the growing use of equity as collateral and the increased demand for term trades – will be familiar to any active market participant from 2015, but the third – rising costs to the lending agent of providing borrower default protections (commonly referred to as ‘indemnification’) – has emerged relatively recently, and could assume much greater importance this year.
Recent years have witnessed growth in the use of equities as collateral for stock loans in Europe and there is every reason to expect this to continue in 2016.
According to the most recent report from the International Securities Lending Association (ISLA), dated September 2015 (based on January-June data), the market is moving further toward non-cash collateral, with equities being the main beneficiary. The proportion of total securities loans collateralized with non-cash collateral rose from 55% in the second half of 2014 to 60% in the first six months of 2015; indeed ISLA noted that loans of government bonds in Europe these days are only collateralized using non-cash collateral. Based on data from the four main tri-party service providers in Europe (BNY Mellon, Clearstream, Euroclear and JP Morgan) – which collectively hold the vast majority of non-cash collateral received by lenders – 57% of securities held in tri-party were equities at the end of June 2015, up from 53% six months earlier. Clearly, post-crisis regulatory and macro-economic trends have turned conventional wisdom in the securities lending market (i.e. where asset owners historically lent out equities in return for government bonds as collateral) on its head!
Although low interest rates and the very real possibility of downgrades for OECD government bonds have played their part, Basel III’s Liquidity Coverage Ratio (LCR) and Net Stable Funding Ratio (NSFR) are the key reasons for this switch. These ratios encourage banks to hoard high-quality liquid assets (HQLAs) – largely government bonds, while other aspects of the Basel capital and liquidity framework (which is being rolled out by national regulators up to 2019) punish balance sheet holdings of equity securities. Moreover, lenders that are naturally long on equities can experience operational and cost efficiencies in accepting equities as collateral, even when lending out equities.
That said, there are limits on the use of equities as collateral for stock loans. Some beneficial owners still regard equity as inherently too risky to serve as collateral. Price volatility of equities is undeniably higher than for corporate bonds, for example, but the higher margins for deals backed by equity collateral reflect this volatility and seek to offset the attendant risks. Regulatory issues may stay the hand of certain buy-side market participants – such as public sector pension schemes or mutual funds subject to UCITS V – but other securities lenders can benefit from as much as a doubling of revenues on individual transactions by accepting equities as collateral. In the prevailing environment, this could be the difference between making a trade or not.
Like equity collateral, the trend toward term is already fairly well established and has similar drivers, notably the strain on sell-side balance sheets stemming from Basel III. For this reason, it is likely to continue into 2016 and beyond.
Figures from DataLend suggest that the proportion of three-month or longer loans has increased from 8% at the end of 2013 to 12% by the end of June 2015, at which point open / rolling securities lending transactions were reported at 84% of all transactions. This may appear a gradual shift to the casual observer, but the increase in the volume of three-month-plus loans is a rapid and significant shift in the context of historical trends in the securities lending market.
Again, the key factor is Basel III’s LCR, and its effect on banks’ need to have ready access to HQLAs. The LCR requires banks to hold levels of HQLAs that exceed expected net cash outflows for the next 30 days, creating consistent demand for government bonds. This dictates not only a preference among sell-side borrowers for term, but also for offering evergreen structures, which effectively rolls-over existing loans with minimal effort by counterparties. The impact of the LCR is further underlined by the fact that 24% of all government bond loans in the DataLend universe were for three months or longer at the end of June 2015.
The fixed income side of the securities lending market has always been driven more by the financing needs of the borrower than the intrinsic value of a particular security, but an interesting development in today’s market is that this also now applies to demand for longer-term equities transactions, offering substantial benefits to lenders prepared to accept equities collateral.
For example, lending a US blue-chip stock in return for a basket of MSCI World component equity collateral on an overnight basis might earn a 20 bps return, but the borrower’s demand for term is such that the beneficial owner could be rewarded with a 60% uplift (i.e. 32 bps) by agreeing to a longer-term evergreen structure.
Many lenders fight shy of longer-term transactions due to concerns about locking up their assets, causing potential access problems. But it’s important to remember that term-lending is not a binary decision and need not commit a lender’s entire program. As an agent lender, BNY Mellon works with beneficial owners to identify opportunities and advise on the proportion of a program that might be lent out for longer terms, based on prevailing market circumstances. Moreover, agent lenders can factor in the added complications that can arise in longer-term stock lending – such as quarterly index rebalancing – seeking to ensure minimal impact. As such, for more passive beneficial owners in particular, we believe that term lending using equity as collateral will continue to represent a good opportunity in the year ahead and beyond, offering revenue uplift and stability of supply.
At the risk of repetition, the third key trend for 2016 can be traced to the Basel regulations too. Unfortunately, it’s one with little upside for the securities lending community, but there is an opportunity to minimize the downside.
As mentioned above, Basel III’s guidelines are being rolled out over the course of several years, with different deadlines for various aspects of the new regulatory framework. One issue that has been on the radar for a couple of years, due to Basel III’s proposal on risk-based capital and leverage requirements, is the potential for agent lenders to hold more capital against the borrower default protections they offer to lending clients (prime brokers acting for borrowers also face higher capital charges). The cost of providing these ‘indemnifications’ could rise steeply as banks come into line with the new rules.
This means that the hurdle rate for agent lenders executing transactions on behalf of securities lending clients will be significantly higher than previously, causing banks to be more cautious in the new business they take on and more precise when calculating the likely outcome of proposed transactions involving existing clients.
Agent lenders will continue to offer indemnification to clients, recognizing that it has become a critical pre-requisite to stock lending for many risk-averse beneficial owners that require a remedy providing for the replacement of loaned securities and/or protection against a shortfall in the value of collateral in the event of a borrower default. It is inevitable, however, that clients will see shifts in pricing from agent lenders and should adjust their approach accordingly in order to pursue profitable opportunities and avoid situations where the capital implications are likely to prove counterproductive.
Beneficial owners should expect different fee splits across their lending programs reflecting the cost of capital to agent lenders for different transactions, rather than a standard approach across all trades. One way of reducing the impact of the regulatory change could be for lenders to move in favor of transactions in which the currency of the loan and the underlying collateral are correlated, as this can significantly reduce the cost of capital for the lending agent providing protections.
In a fast-changing regulatory and macro-economic environment, where interactions between different forces can lead to unpredictable outcomes, securities lenders will achieve the best returns by remaining alert to the possibility of change. Securities lending volumes were buoyant in 2015, in part driven by the demand for HQLAs on the sell-side, but also by the ongoing search for additional yield on the buy-side amid continued macro-economic uncertainty. But the market continues to be reshaped by regulation as much as pure demand and supply forces. Eighteen months ago the use of equity collateral was an emerging trend. Now, it is so dominant that market participants are being disadvantaged if they do not follow suit. Indemnification costs will be a major theme for 2016, changing the economics of transactions along the lines suggested above, but perhaps in other ways too. As such, beneficial owners should be prepared to respond quickly. I will be sharing my thoughts on evolving market trends on a quarterly basis across the year, but BNY Mellon’s agent lending staff are always available to discuss challenges and opportunities as they arise.
BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation and may be used as a generic term to reference the corporation as a whole and/or its various subsidiaries generally. This material and any products and services may be issued or provided under various brand names in various countries by duly authorized and regulated subsidiaries, affiliates, and joint ventures of BNY Mellon, which may include any of the following. The Bank of New York Mellon, at 225 Liberty St, NY, NY USA, 10286, a banking corporation organized pursuant to the laws of the State of New York, and operating in England through its branch at One Canada Square, London E14 5AL, UK, registered in England and Wales with numbers FC005522 and BR000818. The Bank of New York Mellon is supervised and regulated by the New York State Department of Financial Services and the US Federal Reserve and authorized by the Prudential Regulation Authority. The Bank of New York Mellon, London Branch is subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority. Details about the extent of our regulation by the Prudential Regulation Authority are available from us on request. The Bank of New York Mellon SA/NV, a Belgian public limited liability company, with company number 0806.743.159, whose registered office is at 46 Rue Montoyerstraat, B-1000 Brussels, Belgium, authorized and regulated as a significant credit institution by the European Central Bank (ECB), under the prudential supervision of the National Bank of Belgium (NBB) and under the supervision of the Belgian Financial Services and Markets Authority (FSMA) for conduct of business rules, and a subsidiary of The Bank of New York Mellon. The Bank of New York Mellon SA/NV operates in England through its branch at 160 Queen Victoria Street, London EC4V 4LA, UK, registered in England and Wales with numbers FC029379 and BR014361. The Bank of New York Mellon SA/NV (London Branch) is authorized by the ECB and subject to limited regulation by the Financial Conduct Authority and the Prudential Regulation Authority. Details about the extent of our regulation by the Financial Conduct Authority and Prudential Regulation Authority are available from us on request The Bank of New York Mellon SA/NV operating in Ireland through its branch at 4th Floor Hanover Building, Windmill Lane, Dublin 2, Ireland trading as The Bank of New York Mellon SA/NV, Dublin Branch, is authorised by the ECB and is registered with the Companies Registration Office in Ireland No. 907126 & with VAT No. IE 9578054E. The Bank of New York Mellon, Singapore Branch, subject to regulation by the Monetary Authority of Singapore. The Bank of New York Mellon, Hong Kong Branch, subject to regulation by the Hong Kong Monetary Authority and the Securities & Futures Commission of Hong Kong. If this material is distributed in Japan, it is distributed by The Bank of New York Mellon Securities Company Japan Ltd, as intermediary for The Bank of New York Mellon. Not all products and services are offered in all countries.
The information contained in this material is intended for use by wholesale/professional clients or the equivalent only and is not intended for use by retail clients. If distributed in the UK, this material is a financial promotion.
This material, which may be considered advertising, is for general information purposes only and is not intended to provide legal, tax, accounting, investment, financial or other professional advice on any matter. This material does not constitute a recommendation by BNY Mellon of any kind. Use of our products and services is subject to various regulations and regulatory oversight. You should discuss this material with appropriate advisors in the context of your circumstances before acting in any manner on this material or agreeing to use any of the referenced products or services and make your own independent assessment (based on such advice) as to whether the referenced products or services are appropriate or suitable for you. This material may not be comprehensive or up to date and there is no undertaking as to the accuracy, timeliness, completeness or fitness for a particular purpose of information given. BNY Mellon will not be responsible for updating any information contained within this material and opinions and information contained herein are subject to change without notice. BNY Mellon assumes no direct or consequential liability for any errors in or reliance upon this material.
This material may not be distributed or used for the purpose of providing any referenced products or services or making any offers or solicitations in any jurisdiction or in any circumstances in which such products, services, offers or solicitations are unlawful or not authorized, or where there would be, by virtue of such distribution, new or additional registration requirements.
Neither BNY Mellon nor any of its respective officers, employees or agents are, by virtue of providing the materials or information contained herein, acting as an adviser to any recipient (including a “municipal advisor” within the meaning of Section 15B of the Securities Exchange Act of 1934, as amended, “Section 15B”), do not owe a fiduciary duty to the recipient hereof pursuant to Section 15B or otherwise, and are acting only for their own interests.
The views expressed within this article are those of the author only and not necessarily those of BNY Mellon or any of its subsidiaries or affiliates, which make no representation as to the accuracy, completeness, timeliness, or fitness for a specific purpose of the information provided in this document. Material contained in this article is intended for information purposes only and not to provide professional counsel or investment advice on any matter. No statement or expression is an offer or solicitation to buy or sell any products or services mentioned.
All references to dollars are in US dollars unless specified otherwise.
This material may not be reproduced or disseminated in any form without the prior written permission of BNY Mellon. Trademarks, logos and other intellectual property marks belong to their respective owners.
The Bank of New York Mellon, member FDIC.
© 2016 The Bank of New York Mellon Corporation. All rights reserved.
Head of Securities Finance New Business Development – EMEA
BNY Mellon Markets